Clinical trials
Phase 1/2 Carcinoma in Situ trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Altor BioScience | 1 |
| National Cancer Institute (NCI) | 1 |
| Ohio State University | 1 |
| enGene, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma in Situ | 4 |
| Non-Muscle Invasive Bladder Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Carcinoma, Transitional Cell | 1 |
| Neoplasms | 1 |
| Papillomavirus Infections | 1 |
| Recurrence | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Uterine Cervical Dysplasia | 1 |
| Vulvar Diseases | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.